Pure Global AI
NCT06298006Recruiting

A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients

Uppföljning av Psykiatriska, Kognitiva Och Neurologiska Symtom Hos Post COVID-19 Patienter.
Region Örebro CountyClinicalTrials.govother
Verified
Study focus
Disease/Condition
COVID-19
Drug/Device/Intervention
Follow-up
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Region Örebro County
Location
Örebro, Sweden
Timeline & enrollment
Phase
N/A
Start date
Feb 22, 2022
End date
Jun 30, 2027
Enrollment
100 participants
Primary outcome

Change in cognitive functions measured with Mindmore and change in cognitive profile in Mindmore.,Symptom improvement in depression,Self-reported symptom improvement in depression,Grade of self-reported mental fatigue,Rate of self-reported symptoms suggestive of post-traumatic stress disorder (PTSD),Grade of self-reported stress,Grade of self-reported cognitive failures in everyday life

Summary

The prospective, longitudinal, open observational study monitors patients with cognitive and
 neuropsychological symptoms after COVID-19 infection, in a longitudinal manner to see how the
 disease has affected their physical, psychological and cognitive function, their ability to
 be active, return to work, their health-related quality of life in correlation with potential
 diagnostic and prognostic markers.

ICD-10 classifications
COVID-19, virus identifiedCOVID-19, virus not identifiedCoronavirus infection, unspecified siteViral infection, unspecifiedRift Valley fever
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06298006
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06298006 through Pure Global AI's free database. This phase not specified trial is sponsored by Region Örebro County and is currently Recruiting. The study focuses on COVID-19. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.